Impact story

Disinfectant testing against SARS-CoV-2

Wageningen Bioveterinary Research (WBVR) is able to test whether your disinfectant inactivates coronavirus SARS-CoV-2, according to the NEN 14674 norm or alternatively adapt the procedure to your (governmental) requirements.

Test and prove the efficacy

The SARS-CoV-2 pandemic has impacted every aspect of our daily life. To prevent spreading of this coronavirus, disinfecting hands and materials in households and hospitals is an important preventive measure. WBVR can test and prove the efficacy of disinfectants against SARS-CoV-2 compliant with regulatory requirements.

At Mirius, we are delighted and honoured to collaborate with the scientists of WBVR. This study outcome brings additional confidence to Hycolin users as being truly effective against the virological cause of COVID-19.
Dr Richard Hastings - Microbiologist and technical lead at Mirius

Benefits of efficacy testing

Disinfectant product positioning will strongly gain power by directly proving its efficacy to inactivate SARS-CoV-2. Our independent, third-party validation supports consumer confidence and makes the product stand out from its competitors. WBVR can deliver a fast turnover time and can customize the assay to your needs.

Please feel free to get in touch with our expert to learn more.

Disinfectants for veterinary viruses

Interested in testing disinfectants for specific veterinary viruses?